Target intelligence / Profile preview

Free radicals in chemical antioxidant assays

Molecular classification
Reactive species, Free radicals, Oxidants, Other
01

Overview

Free radicals in chemical antioxidant assays are synthetic or naturally occurring reactive species employed in in vitro experiments to quantify the antioxidant potential of substances. These assays, such as the DPPH (2,2-diphenyl-1-picrylhydrazyl) or ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) tests, rely on the ability of a test compound to donate electrons or hydrogen atoms to neutralize the radical, typically resulting in a measurable color change (PMID: 23769221). While these specific chemical radicals are not therapeutic targets, they serve as models for endogenous reactive oxygen species (ROS) like superoxide and hydroxyl radicals that cause oxidative stress in vivo (PMID: 28249118). In biological systems, excessive free radical production is linked to cellular damage and the progression of diseases such as cancer, neurodegeneration, and cardiovascular disorders (PMID: 24511325). Antioxidant drugs and supplements interact with these species by scavenging them directly or by inducing protective enzymatic pathways to maintain redox homeostasis (PMID: 11327322). The use of these assays allows researchers to screen for potential therapeutic agents that can mitigate oxidative damage in clinical settings, although the correlation between in vitro capacity and in vivo efficacy remains a significant challenge.

Other names
DPPH (2,2-diphenyl-1-picrylhydrazyl)ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid))Reactive oxygen speciesROSReactive nitrogen speciesRNSOxidantsAntioxidant capacity assays
02

Mechanism of action

Neutralization of reactive species through electron transfer (SET) or hydrogen atom transfer (HAT) mechanisms (PMID: 23769221).

03

Biological functions

Oxidative stress inductionCell signalingMacromolecule damageOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Antioxidant paradox (excessive antioxidants may interfere with beneficial ROS signaling)Potential for pro-oxidant effects at high concentrationsLimited clinical translation from in vitro assay results
06

Interacting drugs

Ascorbic acid

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsIsoprostanes

Beyond the preview

Go deeper on Free radicals in chemical antioxidant assays.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free radicals in chemical antioxidant assays.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call